By THE ASSOCIATED PRESS
Allergan, the maker of Botox and other medicines, said it would buy back up to $10 billion in stock with proceeds from sale of its generic drug business.
Published: May 11, 2016 at 12:00AM
from NYT Business Day http://ift.tt/1T3T65R
from WordPress http://ift.tt/1qbOMsZ
via Hadi Aboukhater
No comments:
Post a Comment